MarketResearchFuture.com adds “Dermal Fillers Market – 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2023” reports to its database.
TRY FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/3893 .
Global dermal fillers market is expected to grow at the CAGR of ~12.5% during the forecast period and is estimated to reach USD 10,008.4 million by 2023.
The recent market developments has necessitated a ‘see through’ approach so as to avoid the slippery slope generated by the changing paradigms resulting from the powerful forces of economy, business models, competition and others. “Market Research future” presents its latest report titled “World Dermal Fillers Market –forecast till 2023” to help clear the blur resulting from these developments and to give the reader a clear picture of the possibilities and nuisances lying ahead!
Regional Analysis of Global Dermal Fillers Market:
Considering the global scenario of the market, Americas are the top contributors in this market. The Americas mainly include North America and Latin America. Due to large amount of money invested R&D and technological advanced products, US dermal fillers market was valued USD 1,074.0 million in 2016. Due to rapid adoption of new products and advanced therapies, Europe is the second largest market for Dermal Fillers and is expected to reach USD 10,008.4 million by 2023. France is dominating this market while UK is the fastest growing dermal fillers market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, and rising healthcare expenditure. Asia Pacific dermal fillers market is expected to grow at a CAGR of 13.1% during the forecast period. Middle East & Africa is expected to have limited growth. Middle East is dominating this market by holding 79.4% of the market share.
The report for Global Dermal Fillers Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions
Key Players in the Dermal Fillers Market:
ALLERGAN (Republic of Ireland), Dr. Korman Laboratories (Israel), GALDERMA (Switzerland), Integra Lifesciences (US), Merz Pharma (Germany), Sinclair Pharma (UK), and Teoxane laboratories (Switzerland). The major players focus on the development of products useful for particular segment such as nutritional products for adults, children and geriatric population. The major players focus on the development of products useful for particular segment such as nutritional products for adults, children and geriatric population.
Dermal Fillers Market-Overview:
The Global Dermal Fillers Market is expected grow at a fast pace owing to an increasing trend of using anti-ageing treatments, and demand for various devices for dermatology procedures in the market. Rising awareness about skin care and extensive demand for diagnostic and treatment services for skin diseases also influence the growth of the market.
Increasing number of cosmetic surgeries as well as lifestyle changes further accelerate the market growth. There is an increases in the number of facial injectable surgeries performed on women, as their demand is increasing from last few years, thus boosting the development of the market. Around 91% of facial injectable surgeries are performed on women across the globe. Additionally, availability of well qualified and highly skilled healthcare professional such as dermatologist and surgeons increase the demand for dermal fillers and other dermatology devices and appliances in the market.
Technological advancement further determines the development of dermal fillers market as the key players are now engaged in product differentiation strategy, which is important to sustain the company`s growth and strength its geographical presence.
Strategic approaches adopted help the major players in the market to sustain their growth and develop their business in various geographical areas across the globe. Agreements and collaborations, mergers and acquisitions, and new product launches are various strategies followed by the key players. This help the companies to reach untapped markets in developing nations of the worlds, thus reducing the supply demand gap.
Allergan has a wind range of products which provides efficient treatment for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women’s health, urology and anti-infective therapeutic categories
June 2017: Allergan announces launch of artificial tear refresh optive mega-3.
June, 2017: Allergan announced the acquisition of Keller Medical, adding Keller Funnel to co’s leading plastic surgery portfolio.
March 2017: Allergan and Editas Medicine enter into strategic research and development alliance. This alliance is to discover and develop Crispr Genome editing medicines for eye diseases.
Galderma is a global leader in dermatology and has strategic partnerships with brands like Soolantra, Tri-Luma, Loceryl, BenzacEpiduo, Oracea, Differin, Mirvaso, Cetaphil, Excipial, Daylong, Restylane, Emervel and many other brands. The company focus on the production of innovative solutions in the field of dermatology for the treatment of various skin diseases such as acne, rosacea, psoriasis, steroid-responsive dermatoses, onychomycosis, pigmentary disorders, skin cancer and other various fields in skin care.
January 2017: Galderma launched two new dermal fillers. In December, Galderma received FDA approval for a pair of next-generation hyaluronic acid (HA) dermal fillers: Restylane Refyne and Restylane Defyne.
January 2017: Galderma announces approval of Azzalure in Europe for treatment of lateral canthal lines in adults. Azzalure, a product in-licensed from Ipsen, received positive opinion from the French regulatory authority, ANSM, for treatment of lateral canthal lines (crow’s feet), either alone or in combination with treatment of glabellar lines.
July 2016: Chugai and Galderma Announce Global License Agreement for Nemolizumab (CIM331), Novel Biologic for Skin Diseases. The primary aim of this agreement is to improve atopic dermatitis by breaking the itch-scratch cycle which has great expectation for nemolizumab.
January 2016: Maruho and Galderma to Join Forces in a Strategic Alliance in Japan. One of the major reasons of this strategic alliance is that galderma will permit maruho to additionally promote their products in japan in the field of dermatology.
February 2017: Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson.
February 2016: Integra Lifesciences Holdings Corp announces Service Alliance Agreement with PREZIO Health. By this Integra life science will have an authorized service provider for surgical devices and instruments.
May 2015: Integra Lifesciences completes acquisition of TEI Biosciences and TEI Medical. This acquisition Integra will expand their biomedical product profile with collagen based products strengthening the product portfolio of Integra Life Science.
CHAPTER 1. REPORT PROLOGUE
CHAPTER 2. MARKET INTRODUCTION
2.1 Specification of Dermal Fillers 12
2.1.1 Hyaluronic Acid 12
2.1.2 Botulinum Toxin 12
2.1.3 Collagen 13
2.1.4 Polymers and Particles 13
2.2 Scope Of Study 14
2.2.1 Research Objective 14
2.2.2 Assumptions & Limitations 14
220.127.116.11 Assumptions 14
18.104.22.168 Limitations 14
2.3 Market Structure 15
CHAPTER 3. RESEARCH METHODOLOGY
3.1 Primary Research 17
3.2 Secondary Research 17
3.3 Market Size Estimation 17
AVAIL AMAZING DISCOUNT ON REPORT @ https://www.marketresearchfuture.com/check-discount/3893 .
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312